391 related articles for article (PubMed ID: 15049127)
1. [Research and development of the free radical scavenger edaravone as a neuroprotectant].
Watanabe T; Tanaka M; Watanabe K; Takamatsu Y; Tobe A
Yakugaku Zasshi; 2004 Mar; 124(3):99-111. PubMed ID: 15049127
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent].
Tanaka M
Nihon Yakurigaku Zasshi; 2002 May; 119(5):301-8. PubMed ID: 12061142
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury.
Yoshida H; Yanai H; Namiki Y; Fukatsu-Sasaki K; Furutani N; Tada N
CNS Drug Rev; 2006; 12(1):9-20. PubMed ID: 16834755
[TBL] [Abstract][Full Text] [Related]
4. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical scavenger, for treatment of cardiovascular diseases.
Higashi Y; Jitsuiki D; Chayama K; Yoshizumi M
Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):85-93. PubMed ID: 18221078
[TBL] [Abstract][Full Text] [Related]
5. The synergetic effect of edaravone and borneol in the rat model of ischemic stroke.
Wu HY; Tang Y; Gao LY; Sun WX; Hua Y; Yang SB; Zhang ZP; Liao GY; Zhou QG; Luo CX; Zhu DY
Eur J Pharmacol; 2014 Oct; 740():522-31. PubMed ID: 24975100
[TBL] [Abstract][Full Text] [Related]
6. Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney.
Doi K; Suzuki Y; Nakao A; Fujita T; Noiri E
Kidney Int; 2004 May; 65(5):1714-23. PubMed ID: 15086910
[TBL] [Abstract][Full Text] [Related]
7. Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo.
Inokuchi Y; Imai S; Nakajima Y; Shimazawa M; Aihara M; Araie M; Hara H
J Pharmacol Exp Ther; 2009 May; 329(2):687-98. PubMed ID: 19201991
[TBL] [Abstract][Full Text] [Related]
8. Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers.
Green AR; Ashwood T
Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):109-18. PubMed ID: 15857295
[TBL] [Abstract][Full Text] [Related]
9. Edaravone prevented deteriorated cardiac function after myocardial ischemia-reperfusion via inhibiting lipid peroxidation in rat.
Yagi H; Horinaka S; Matsuoka H
J Cardiovasc Pharmacol; 2005 Jul; 46(1):46-51. PubMed ID: 15965354
[TBL] [Abstract][Full Text] [Related]
10. Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model.
Ueno Y; Zhang N; Miyamoto N; Tanaka R; Hattori N; Urabe T
Neuroscience; 2009 Aug; 162(2):317-27. PubMed ID: 19409967
[TBL] [Abstract][Full Text] [Related]
11. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain.
Zhang N; Komine-Kobayashi M; Tanaka R; Liu M; Mizuno Y; Urabe T
Stroke; 2005 Oct; 36(10):2220-5. PubMed ID: 16166574
[TBL] [Abstract][Full Text] [Related]
12. Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage.
Nakamura T; Kuroda Y; Yamashita S; Zhang X; Miyamoto O; Tamiya T; Nagao S; Xi G; Keep RF; Itano T
Stroke; 2008 Feb; 39(2):463-9. PubMed ID: 18096835
[TBL] [Abstract][Full Text] [Related]
13. A free radical scavenger edaravone suppresses systemic inflammatory responses in a rat transient focal ischemia model.
Fujiwara N; Som AT; Pham LD; Lee BJ; Mandeville ET; Lo EH; Arai K
Neurosci Lett; 2016 Oct; 633():7-13. PubMed ID: 27589890
[TBL] [Abstract][Full Text] [Related]
14. The novel antioxidant edaravone: from bench to bedside.
Watanabe T; Tahara M; Todo S
Cardiovasc Ther; 2008; 26(2):101-14. PubMed ID: 18485133
[TBL] [Abstract][Full Text] [Related]
15. Edaravone for the treatment of acute cerebral infarction: role of endothelium-derived nitric oxide and oxidative stress.
Higashi Y
Expert Opin Pharmacother; 2009 Feb; 10(2):323-31. PubMed ID: 19236202
[TBL] [Abstract][Full Text] [Related]
16. The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells.
Kikuchi K; Kawahara K; Tancharoen S; Matsuda F; Morimoto Y; Ito T; Biswas KK; Takenouchi K; Miura N; Oyama Y; Nawa Y; Arimura N; Iwata M; Tajima Y; Kuramoto T; Nakayama K; Shigemori M; Yoshida Y; Hashiguchi T; Maruyama I
J Pharmacol Exp Ther; 2009 Jun; 329(3):865-74. PubMed ID: 19293391
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of edaravone on cognitive deficit, oxidative stress and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats.
Zhou S; Yu G; Chi L; Zhu J; Zhang W; Zhang Y; Zhang L
Neurotoxicology; 2013 Sep; 38():136-45. PubMed ID: 23932983
[TBL] [Abstract][Full Text] [Related]
18. Free-radical scavenger edaravone treatment confers neuroprotection against traumatic brain injury in rats.
Wang GH; Jiang ZL; Li YC; Li X; Shi H; Gao YQ; Vosler PS; Chen J
J Neurotrauma; 2011 Oct; 28(10):2123-34. PubMed ID: 21732763
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of MCI-186, a free radical scavenger, on cerebral ischemia following rat middle cerebral artery occlusion.
Mizuno A; Umemura K; Nakashima M
Gen Pharmacol; 1998 Apr; 30(4):575-8. PubMed ID: 9522178
[TBL] [Abstract][Full Text] [Related]
20. Edaravone, a free radical scavenger, attenuates cerebral infarction and hemorrhagic infarction in rats with hyperglycemia.
Okamura K; Tsubokawa T; Johshita H; Miyazaki H; Shiokawa Y
Neurol Res; 2014 Jan; 36(1):65-9. PubMed ID: 24074041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
